Research progress in drug toxicology based on systems biology

LOU Yi-jia

DOI: https://doi.org/10.3867/j.issn.1000-3002.2012.04.002

2012-01-01

Abstract:The research of toxicology based on systems biology has come into vogue.Systems toxicology analyses rely on experimental ′omics′ technologies that are capable of measuring changes in large numbers of variables,often at a genome-wide level,to build networks for analyzing drug toxic action.A major use of ′omics′ technologies is to relate the genomic status of an individual to the therapeutic efficacy of a drug of interest.Combining pathway and network analyses,toxicokinetic and toxicodynamic models,and a knowledge of polymorphisms in the genome will enable the development of predictive models of therapeutic toxic efficacy.Network analyses based on publicly available databases such as the U.S.Food and Drug Administration′s Adverse Event Reporting System allow us to develop an initial understanding of the context within which molecular-level drug-target interactions can lead to distal effectors in a process that results in adverse phenotypes at the organ and organism levels.This review focuses on recent advancements in the application of genomic and genetic data to drug safety and highlights recent successes and current knowledge gaps in the following areas: ① the discovery of toxicity biomarkers and identification of compounds that are predicted to cause toxicity,② the identification of susceptible individuals,and ③ integration of various ′omics′ datasets to improve understanding of toxicity mechanisms within a biological system.